Postbiotics: Novel Solutions for Digestive Health

Discover an informative webinar discussing the link between digestive health and pro-/post-biotics using data from the first human clinical data on patients with diarrhea-predominant irritable bowel syndrome (IBS-D).

Increasingly, pre-clinical and clinical research supports the importance of gut health in a wide variety of physiological systems, ranging from digestive health and immune function support to cardiovascular and mental health. With nearly 80 percent of consumers recognizing the link between digestive health and overall well-being, it is not surprising this category is the largest among biotic products.

ADM’s most recent clinical study uses the dual probiotic and postbiotic Bifidobacterium longum ES1 in a population of adults with diarrhea-predominant IBS-D. In this webinar, the speaker will walk through the main findings from this study and the science around digestive health and postbiotics.

By attending this webinar, the attendees will gain insights into the following:

• Latest clinical trial data from a large multi-centre randomized controlled trial
• Explore the use of postbiotics for digestive health
• First human clinical data for a dual pro- and post-biotic

Register for this webinar today to explore invaluable insights from a large multi-center randomized controlled trial and first human clinical data for a novel dual pro- and postbiotic for diarrhea-predominant IBS-D.

Speaker

Vineetha Vijayakumar, PhD, MSc, Head of Medical Affairs, ADM

Vineetha Vijayakuma is the Head of Medical Affairs for ADM Health & Wellness, based in London, UK. In this role Vineetha is responsible for the dissemination of clinical research findings for ADM Health & Wellness to both internal and external stakeholders by authoring scientific publications/reviews, engage and support in scientific exchange through conferences, educate healthcare providers, and contribute to evidence-based decision-making for the business. She has a cross functional role in ensuring a collaborative work environment between Marketing, Sales, Commercial, Regulatory and Medical affairs teams. She also leads Metabolic health and Vaccine clinical research for ADM Health and Wellness.

Vineetha joined ADM in 2019 and has been involved in multiple research projects, including immunity, low mood, skin health and weight management. She is the UK DE&I Champion for ADM Protexin.

She was awarded European Marie Curie fellowship for her PhD in Cancer Cell Biology from King’s College London. She holds a BSc(Hons) and MSc(Hons) in Molecular Biology from École Normale Supérieure de Lyon, France. She has over 7 years of postdoctoral experience in Neurodevelopment from the Institute of Psychiatry, Psychology and Neuroscience at King’s College London.

Message Presenter